Efficacy and safety of concentration-controlled everolimus with reduced-dose cyclosporine in Japanese de novo renal transplant patients: 12-month results
about
Oedema, solid organ transplantation and mammalian target of rapamycin inhibitor/proliferation signal inhibitors (mTOR-I/PSIs)mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis.Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients.CMV and BKPyV Infections in Renal Transplant Recipients Receiving an mTOR Inhibitor-Based Regimen Versus a CNI-Based Regimen: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials.Calcineurin Inhibitor Minimization, Conversion, Withdrawal, and Avoidance Strategies in Renal Transplantation: A Systematic Review and Meta-Analysis.Mycophenolic acid AUC in Thai kidney transplant recipients receiving low dose mycophenolate and its association with UGT2B7 polymorphisms.Effects of mTOR inhibition on cardiac and adipose tissue pathology and glucose metabolism in rats with metabolic syndrome.Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant p
P2860
Q26851935-DBFCDE6F-8C8E-43CC-B75A-8F36ACD73F9DQ33424013-5E078F35-EAD7-4F15-B758-34D66CED4C95Q38668601-CE987816-A65C-493C-9EC0-3670F828847BQ38747503-F5E8D8BE-20F7-400D-8A9F-76D1FE168AC7Q38779769-1A5D8307-94EF-4B62-9991-B72DFF1C7F09Q43070323-00D3CFC6-DB44-46D6-8DF8-8F78BDB2CA94Q47103498-2559A1B8-AB06-4C63-BBA3-18AF5A2DD8A8Q56970934-916CC2D8-C983-40F6-B39A-1FA5F8A3A403
P2860
Efficacy and safety of concentration-controlled everolimus with reduced-dose cyclosporine in Japanese de novo renal transplant patients: 12-month results
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy and safety of concent ...... ant patients: 12-month results
@en
Efficacy and safety of concent ...... nt patients: 12-month results.
@nl
type
label
Efficacy and safety of concent ...... ant patients: 12-month results
@en
Efficacy and safety of concent ...... nt patients: 12-month results.
@nl
prefLabel
Efficacy and safety of concent ...... ant patients: 12-month results
@en
Efficacy and safety of concent ...... nt patients: 12-month results.
@nl
P2093
P2860
P356
P1476
Efficacy and safety of concent ...... ant patients: 12-month results
@en
P2093
Catherine Cornu-Artis
Eiji Kobayashi
Kazuharu Uchida
Kota Takahashi
Norio Yoshimura
Rie Teshima
Satoshi Teraoka
Shiro Takahara
P2860
P2888
P356
10.1186/2047-1440-2-14
P577
2013-07-16T00:00:00Z
P5875
P6179
1004782628